Skip to main content
Kent Academic Repository

Browse by Person (creator, editor, contributor, etc.)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Article
Number of items: 3.

Article

Yap, T. A. and Walton, M. I. and Grimshaw, K. M. and te Poele, R. H. and Eve, P. D. and Valenti, M. R. and de Haven Brandon, A. K. and Martins, V. and Zetterlund, A. and Heaton, S. P. and Heinzmann, K. and Jones, P. S. and Feltell, R. E. and Reule, M. and Woodhead, S. J. and Davies, T. G. and Lyons, J. F. and Raynaud, F. I. and Eccles, S. A. and Workman, P. and Thompson, N. T. and Garrett, Michelle D. (2012) AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity. Clinical Cancer Research, 18 (14). pp. 3912-3923. ISSN 1078-0432. (doi:https://doi.org/10.1158/1078-0432.CCR-11-3313) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

Yap, T. A. and Walton, M. I. and Hunter, L.-J. K. and Valenti, M. and de Haven Brandon, A. and Eve, P. D. and Ruddle, R. and Heaton, S. P. and Henley, A. and Pickard, L. and Vijayaraghavan, G. and Caldwell, J. J. and Thompson, N. T. and Aherne, W. and Raynaud, F. I. and Eccles, S. A. and Workman, P. and Collins, I. and Garrett, Michelle D. (2010) Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930. Molecular Cancer Therapeutics, 10 (2). pp. 360-371. ISSN 1535-7163. (doi:https://doi.org/10.1158/1535-7163.MCT-10-0760) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

Grimshaw, K. M. and Hunter, L.-J. K. and Yap, T. A. and Heaton, S. P. and Walton, M. I. and Woodhead, S. J. and Fazal, L. and Reule, M. and Davies, T. G. and Seavers, L. C. and Lock, V. and Lyons, J. F. and Thompson, N. T. and Workman, P. and Garrett, Michelle D. (2010) AT7867 Is a Potent and Oral Inhibitor of AKT and p70 S6 Kinase That Induces Pharmacodynamic Changes and Inhibits Human Tumor Xenograft Growth. Molecular Cancer Therapeutics, 9 (5). pp. 1100-1110. ISSN 1535-7163. (doi:https://doi.org/10.1158/1535-7163.MCT-09-0986) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

This list was generated on Wed May 22 17:39:31 2019 BST.